DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 06 · Volume 62 · 1989 DOI: 10.1055/s-009-45136

Review Article

  • 648
    Thomas, Duncan P:

    Biologicals, Standards and Heparin

    • Original Article

  • 651
    Tran-Thang, Chiên; Fasel-Felley, Josette; Pralong, Gerard; Hofstetter, Jean-René; Bachmann, Fedor; Kruithof, Egbert K O:

    Plasminogen Activators and Plasminogen Activator Inhibitors in Liver Deficiencies Caused by Chronic Alcoholism or Infectious Hepatitis

  • 654
    Hasselaar, Paula; Derksen, Ronald H W M; Oosting, Janine D; Blokzijl, Laya; de Groot, Philip G:

    Synergistic Effect of Low Doses of Tumor Necrosis Factor and Sera from Patients with Systemic Lupus Erythematosus on the Expression of Procoagulant Activity by Cultured Endothelial Cells

  • 661
    Al-Mondhiry, Hamid; Wallin, Reidar:

    Synthesis of Vitamin K-Dependent Proteins by Cultured Human Tumor Cells

  • 667
    Otter, M; Van Berkel, Th J C; Rijken, D C:

    Binding and Degradation of Tissue-Type Plasminogen Activator by the Human Hepatoma Cell Line Hep G2

  • 673
    Engesser, L; Brommer, E J P; Kluft, C; Briët, E:

    Elevated Plasminogen Activator Inhibitor (PAI), a Cause of Thrombophilia? – A Study in 203 Patients with Familial or Sporadic Venous Thrombophilia

  • 681
    Boissel, J P; Peyrieux, J C; Destors, J M:

    Is It Possible to Reduce the Risk of Cardiovascular Events in Subjects Suffering from Intermittent Claudication of the Lower Limbs?

  • 686
    Levi, Marcel; ten Cate, Jan W; Dooijewaard, Gerard; Sturk, Augueste; Brommer, Emile J P; Agnelli, Giancarlo:

    DDAVP Induces Systemic Release of Urokinase-Type Plasminogen Activator

  • 690
    López-Fernández, M F; López-Berges, C; Fermoso, J; Martín-Pascual, A; Sánchez-Hernández, J J; López-Borrasca, A; Batlle, J:

    High Levels of Plasma FVIII and vWF in the Toxic Epidemic Syndrome Patients

  • 694
    Gómez, C; Páramo, J A; Colucci, M; Rocha, E:

    Effect of Heparin and/or Antithrombin III on the Generation of Endotoxin-Induced Plasminogen Activator Inhibitor

  • 699
    Aerts, Rob J; Gillis, Karin; Pannekoek, Hans:

    Single-Chain and Two-Chain Tissue-Type Plasminogen Activator (t-PA) Bind Differently to Cultured Human Endothelial Cells

  • 704
    Ogilvie, Mary L; Byl, JoAnn Wilson; Gartner, T Kent:

    Platelet Aggregation Is Stimulated by Lactose-lnhibitable Snake Venom Lectins

  • 708
    Marcovina, Santica; Coppola, Raffaella; Valsecchi, Carla; Zoppo, Adele; Gelfi, Cecilia; Mannucci, Pier Mannuccio:

    Monoclonal Antibodies Directed to the Calcium-Free Conformation of Human Protein S

  • 715
    Brenner, B; Zwang, E; Bronshtein, M; Seligsohn, U:

    Von Willebrand Factor Multimer Patterns in Pregnancy-Induced Hypertension

  • 718
    Behnke, O:

    Coated Pits and Vesicles Transfer Plasma Components to Platelet Granules

  • 723
    Kooistra, T; Bosma, P J; Töns, H A M; van den Berg, A P; Meyer, P; Princen, H M G:

    Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human Hepatocytes

  • 729
    Kumar, S; Haigh, J R M; Rhodes, L E; Peaker, S; Davies, J A; Roberts, B E; Feely, M P:

    Poor Compliance Is a Major Factor in Unstable Outpatient Control of Anticoagulant Therapy

  • 733
    Wong, Truman; Pedvis, Lloyd; Frojmovic, Mony:

    Platelet Size Affects both Micro- and Macro-Aggregation: Contributions of Platelet Number, Volume Fraction and Cell Surface

  • 742
    Stigbrand, Torgny; Frängsmyr, Lars; Bergsdorf, Nils; Wallen, Per:

    Characterization of Monoclonal Antibodies to Human Tissue-Type Plasminogen Activator: Catalytic Inhibition and One-Two Chain Discriminatory Reactivities

  • 748
    Lindahl, Tomas L; Sigurdardottir, Olöf; Wiman, Björn:

    Stability of Plasminogen Activator Inhibitor 1 (PAI-1)

  • 752
    Rydzewski, Andrzej; Takada, Yumiko; Takada, Akikazu:

    Stimulation of Plasmin Catalyzed Conversion of SingleChain to Two-Chain Urokinase-Type Plasminogen Activator by Sulfated Polysaccharides

  • 756
    van der Meer, Felix J M; van Tilburg, Nico H; van Wijngaarden, Aat; van der Linden, Irma K; Briët, Ernest; Bertina, Rogier M:

    A Second Plasma Inhibitor of Activated Protein C: α1-Antitrypsin

  • 763
    Mannucci, P M; Valsecchi, C; Krachmalnicoff, A; Faioni, E M; Tripodi, A:

    Familial Dysfunction of Protein S

  • 767
    Jern, Christina; Eriksson, Elsa; Tengborn, Lilian; Risberg, Bo; Wadenvik, Hans; Jern, Sverker:

    Changes of Plasma Coagulation and Fibrinolysis in Response to Mental Stress

  • 772
    Kirschstein, W; Simianer, S; Dempfle, C E; Keller, H; Stegaru, B; Rentrop, P; Heene, D L:

    Impaired Fibrinolytic Capacity and Tissue Plasminogen Activator Release in Patients with Restenosis after Percutaneous Transluminal Coronary Angioplasty (PTCA)

  • 776
    Wilson, J; Orchard, M A; Spencer, A A; Davies, J A; Prentice, C R M:

    Anti-Hypertensive Drugs Non-Specifically Reduce “Spontaneous” Activation of Blood Platelets

  • 781
    Tomita, Yukiharu; Harrison, Janet; Abildgaard, Charles F:

    von Willebrand Factor Multimer Analysis Using a Sensitive Peroxidase Staining Method

  • 784
    Pina-Cabral, J M; Cunha-Monteiro, A; Sousa-Dias, M C; Andrade, J A:

    Effect of Propranolol, Barbiturate Anesthesia and Splenectomy on Factor VIII: C and Plasminogen Activator Release Induced by DDAVP

  • 788
    Xi, Ma; Béguin, S; Hemker, H C:

    The Relative Importance of the Factors II, VII, IX and X for the Prothrombinase Activity in Plasma of Orally Anticoagulated Patients

  • 792
    Kluft, C; Los, P; Clemmensen, I; Brommer, E J P; Gevers Leuven, J A; Boks, A L; Vellenga, E:

    Quantitation of Plasma Levels of Tetranectin - Effects of Oral Contraceptives, Pregnancy, Treatment with L-Asparaginase and Liver Cirrhosis

  • 797
    Berg Schmidt, E; Ernst, E; Varming, K; Pedersen, J O; Dyerberg, J:

    The Effect of n-3 Fatty Acids on Lipids and Haemostasis in Patients with Type lla and Type IV Hyperlipidaemia

  • 802
    de Graaf, Jacques C; Bult, Hidde; de Meyer, Guido R Y; Sixma, Jan J; de Groot, Philip G:

    Platelet Adhesion to Subendothelial Structures under Flow Conditions: No Effect of the Lipoxygenase Product 13-HODE

    • Scientific and Standardization Committee Communications

  • 807
    Owen, John:

    The Utility of Plasma Fibrinopeptide Assays

  • 813
    Francis, Charles W; Mosesson, Michael W:

    Terminology for Fibrinogen γ-Chains Differing in Carboxyl Terminal Amino Acid Sequence

    • Guidelines for SSC Communications

  • 811
    Brettler, Doreen B:

    Proposed Protocol for the Evaluation of the Effect of High Purity Factor Concentrates on the Immune System of Hemophilia Patients

    • Letters to the Editor

  • 815
    Zucker, Marjorie B; Grant, Robert A; Mauss, Evelyn A:

    Failure of 6D1 or Exposure of Platelets to ADP to Affect Agglutination Induced by Wheat Germ Agglutinin

  • 816
    Hanss, M; Martoia, R; Horellou, M H; Samama, M:

    Severe Acquired Deficiency of Vitamin K-Dependent Factors and Resistance to Multiple Vitamin K Injections

  • 817
    Lefrére, J J; Conard, J; Lerable, J; Samama, M:

    Antithrombin III and Hepatocellular Carcinoma

  • 818
    Hermán, Ferenc; Magyar, Kálmán; Kovács, Katalin; Filep, János:

    Decreased Sensitivity of Platelets to Platelet-Activating Factor in Migraine Patients During the Headache-Free Interval

  • 819
    Mannucci, P M; Cugno, M; Mameli, G; Marongiu, F:

    Fibrin(ogen) Peptides in Early Breast Cancer

  • 820
    De Stefano, Valerio; Leone, Giuseppe:

    Antithrombin III Congenital Defects: Revising Classification System